Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Receivables - Other (2019 - 2020)

Updated

Oncotelic Therapeutics' Receivables - Other came in at $70,000 for Q4 2020, down 46.2% from $130,000 a year earlier and unchanged from the prior quarter.

Analysis

Oncotelic Therapeutics (OTLC) Receivables - Other (2019 - 2020) Analysis & Trends

Going back to Q4 2019, Oncotelic Therapeutics' Receivables - Other data covers 5 quarters.

  • Going back by year, Receivables - Other was $130,000 in FY2019.
  • The five-year range for quarterly Receivables - Other is $70,000 (Q1 2020) to $130,000 (Q4 2019).
  • Business Quant data shows OTLC's Receivables - Other at $70,000 (Q3 2020), $70,000 (Q2 2020) and $70,000 (Q1 2020) in the three quarters before Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 Oncotelic Therapeutics 8.28 Mn 7.42 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 70,000.00
Sep 30, 2020 70,000.00
Jun 30, 2020 70,000.00
Mar 31, 2020 70,000.00
Dec 31, 2019 130,000.00
API Access

Oncotelic Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=OTLC&period=max&api_key=YOUR_API_KEY